6-Bromo-7-methyl[1,2,4]triazolo[1,5-a]pyridine

Catalog No.: 
ACTEDN096
CAS No.: 
1172534-83-6
Molecular Formula: 
C7H6BrN3
Molecular Weight: 
212.05
6-Bromo-7-methyl[1,2,4]triazolo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$73.00In stockInquiry
250mg95%$143.00In stockInquiry
1g95%$350.00In stockInquiry
5g95%$1471.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-7-methyl[1,2,4]triazolo[1,5-a]pyridine
IUPAC Name6-bromo-7-methyl-[1,2,4]triazolo[1,5-a]pyridine
MDL No.MFCD12026325
Molecular FormulaC7H6BrN3
Molecular Weight212.05
SMILESCC1=CC2=NC=NN2C=C1Br
InChI KeyUCQVGCGVFICPEY-UHFFFAOYSA-N
Synonym6-Bromo-7-methyl[1,2,4]triazolo[1,5-a]pyridine;6-broMo-7-Methyl-[1;6-bromo-7-methyl-4-hydro-1,2,4-triazolo[1,5-a]pyridine;[1,2,4]Triazolo[1,5-a]pyridine, 6-bromo-7-methyl-
CAS No.1172534-83-6
PubChem CID44118314

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTEDN096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNJZW985 route compound structure diagram
    ACNJZW98598198-48-2In Stock
  4. Then
  5. ACTEDN096 route product structure diagram
    ACTEDN0961172534-83-6In Stock
Inquiry

2. ACTEDN096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEDN096 route product structure diagram
    ACTEDN0961172534-83-6In Stock
Inquiry

3. ACTEDN096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEDN096 route product structure diagram
    ACTEDN0961172534-83-6In Stock
Inquiry

Comments (0)